Recombined diphtheria toxin, preparation method, and application

A diphtheria toxin and recombinant plasmid technology, applied in the field of immune recombinant toxin and its preparation, can solve the problem of no effect on malignant melanoma, and achieve the effect of high hydrophilicity and good extensibility

Inactive Publication Date: 2007-07-25
JILIN AGRICULTURAL UNIV
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Application No. 01138705.X ​​and 01138706.8 Chinese patent applications have constructed a receptor-directed chimeric toxin with a linker sequence and a diphtheria toxin-gonadotropin-releasing chimeric protein. Tests have shown that the above two recombinant toxins have good target targets. It has good therapeutic effect on some cancers, but it has no effect on malignant melanoma. Therefore, it is necessary to construct a recombinant toxin with target specificity for melanoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombined diphtheria toxin, preparation method, and application
  • Recombined diphtheria toxin, preparation method, and application
  • Recombined diphtheria toxin, preparation method, and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1: recombinant plasmid pET28a / prefix body+DAB 389 (Gly 4 Ser) 2 - Construction of αMSH.

[0032] This example describes the recombinant expression plasmid pET28a / prefix+DAB used to express the recombinant toxin of the present invention 389 (Gly 4 Ser) 2 - For the construction strategy and basic method of αMSH, please refer to Figure 1;

[0033] In order to complete the present invention, the recombinant toxin protein of the present invention can be prepared using gene fusion techniques known to those skilled in the art. For this purpose, various DNA manipulations can be performed according to known recombinant DNA techniques (see, for example, Sambrook et al, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, 1989). pET28a / DAB 389 (Gly 4 Ser) 2 EGF was provided by Zhang Guoli, plasmid pET28a(+) (Novagen), recipient bacteria JM109, BL21 (DE3) were purchased from Novagen. PCR kit, DNA Marker DL-2000, DNA recovery kit, restriction e...

Embodiment 2

[0054] Example 2: Expression and Identification of Proteins Expressed by Recombinant Plasmids

[0055] This example describes the induced expression of recombinant toxins of the present invention in E. coli host cells.

[0056] With the recombinant plasmid pET28a / prefix body+DAB that makes in embodiment 1 389 (Gly 4 Ser) 2 - Transform competent Escherichia coli BL21 (λDE3) strain (Novagen) with αMSH, pick positive colonies, and culture them at 37°C according to conventional methods. When OD600nm=0.6, lower the culture temperature to the optimal induction temperature of 30°C and add Induced expression with IPTG inducer, the optimal amount of inducer IPTG is 1.4mmol / L, induced for 6 hours; collect BL21 (λDE3) bacterial cells and suspend in 10 times volume containing 20mmol / LTris-HCL solution, after ultrasonic lysis The supernatant and precipitate were taken separately for SDS-PAGE electrophoresis analysis; the analysis results showed that there was a band with a molecular wei...

Embodiment 3

[0058] Embodiment 3: the purification of fusion protein

[0059] The fusion protein was purified by salting out, Cu Chelating Sepharose Fast Flow affinity chromatography, desalting, and factor Xa digestion;

[0060] Add ammonium sulfate to the bacterial lysate supernatant to make the concentration reach 55%, place at 4°C for 1 hour and centrifuge, dissolve the target protein precipitate with 20mmol / LTris-Cl (containing 2mmol / LEDTA, pH8.0), and collect the supernatant by centrifugation Samples were analyzed and detected by SDS-PAGE. Purify the protein by Cu Chelating Sepharose Fast Flow chromatography, load the sample, and perform gradient elution with A (20mmol / L Tris-Cl, 0.5mol / L NaCl, pH7.5) → B (A solution + 50mmol / L imidazole) (Flow rate is 3mL / min, time 90min), collects each component peak component and carries out SDS-PAGE analysis; The target protein solution is desalted through Superdex G-25 column, collects solution, ultraviolet spectrophotometer analysis and high-pe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This invention discloses a method for preparing recombinant diphtherin and its application. The recombinant diphtherin comprises diphtherin DAB389, a linker peptide (Gly4Ser) 2, and alpha-melanocyte stimulating hormone. The method comprises: (1) preparing a gene fragment of DAB389(Gly4Ser)2-alpha-MSH and a leading peptide, constructing an expression plasmid containing the gene fragment, and transforming Escherichia coli; (2) inducing with IPTG to obtain the target protein, purifying, digesting with Xa factor, and separating to obtain DAB389(Gly4Ser)2-alpha-MSH fusion protein. The method has such advantages as easy purification, and high yield. The recombinant diphtherin has high activity, and can attack and kill malignant melanoma without injuring normal cells, thus can be used to treat malignant melanoma.

Description

technical field [0001] The invention relates to an immune recombinant toxin and its preparation method and application, more specifically a recombinant diphtheria toxin, its preparation method and application. Background technique [0002] Malignant tumors are one of the major diseases that seriously threaten human health and survival. Currently, 12% of the world's deaths are caused by cancer. The incidence of malignant tumors in the world is generally on the rise. According to statistics, by the end of the 1990s, cancer mortality had become the number one killer of human health. Among urban residents, cancer has risen from 11.2% of the causes of death in the 1970s to 18.14% now, ranking first among the causes of death and posing an increasing threat to human health and life. [0003] At present, the traditional tumor treatment methods mainly include surgery, radiotherapy, and chemotherapy, but they are still far from satisfactory. Various countries have been actively com...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/195C07K19/00C12N15/31C12N15/62C12N15/09A61K38/16A61P35/00
Inventor 李泽鸿张国利岳玉环朱平陈萍张林波赵福广吴广谋郑艳军张玲
Owner JILIN AGRICULTURAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap